| Literature DB >> 34208156 |
Diederik R de Boer1, Femke Hoekstra1,2, Kimberley I M Huetink1, Trynke Hoekstra3, Leonie A Krops4, Florentina J Hettinga5.
Abstract
Background: People with physical disabilities and/or chronic diseases report lower levels of physical activity and well-being than the general population, which potentially is exacerbated through the COVID-19 pandemic. This study explored the international literature on physical activity, sedentary behavior and well-being in adults with physical disabilities and/or chronic diseases during the first wave of the pandemic. Method: In a rapid review, we included studies reporting on physical activity, sedentary behavior and/or well-being in adults with physical disabilities and/or chronic diseases. Four databases (Pubmed, CINAHL, PsycInfo, Embase) were searched for studies published until 30 September 2020.Entities:
Keywords: coronavirus; exercise; health; rehabilitation; vulnerable populations
Mesh:
Year: 2021 PMID: 34208156 PMCID: PMC8296179 DOI: 10.3390/ijerph18126342
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Details of the search strategies.
| Database | Search Strategy |
|---|---|
|
| ( (COVID-19 [tiab] OR Sars-CoV-2 [tiab] OR coronavirus [tiab] OR corona virus [tiab]) AND (“Physical activity” [tiab] OR sport [tiab] OR sports [tiab] OR exercise [tiab] OR exercising [tiab] OR “physical training” [tiab] OR “physical performance” [tiab]) OR (COVID-19 [tiab] OR Sars-CoV-2 [tiab] OR coronavirus [tiab] OR corona virus [tiab]) AND (Sedentary behavior [tiab] OR sitting activity [tiab] OR Sedentary inactivity [tiab]) OR (COVID-19 [tiab] OR Sars-CoV-2 [tiab] OR coronavirus [tiab] OR corona virus [tiab]) AND (Well-being [tiab] OR Wellness [tiab] OR Wealth [tiab] OR Welfare [tiab]) ) |
|
| ( (AB (COVID-19 OR Sars-CoV-2 OR coronavirus OR corona virus) OR TI (COVID-19 OR Sars-CoV-2 OR coronavirus OR corona virus)) AND ( (AB (Physical activity OR Sport OR sports OR Exercise OR exercising OR Physical training OR Physical performance) OR TI (Physical activity OR Sport OR sports OR Exercise OR exercising OR Physical training OR Physical performance)) OR (AB (Sedentary behavior OR Sitting activity OR Sedentary inactivity) OR TI (Sedentary behavior OR Sitting activity OR Sedentary inactivity)) OR (AB (Well-being OR Wellness OR Wealth OR Welfare) OR TI (Well-being OR Wellness OR Wealth OR Welfare)) ) ) |
|
| ( (AB (COVID-19 OR Sars-CoV-2 OR coronavirus OR corona virus) OR TI (COVID-19 OR Sars-CoV-2 OR coronavirus OR corona virus)) AND ( (AB (Physical activity OR Sport OR sports OR Exercise OR exercising OR Physical training OR Physical performance) OR TI (Physical activity OR Sport OR sports OR Exercise OR exercising OR Physical training OR Physical performance)) OR (AB (Sedentary behavior OR Sitting activity OR Sedentary inactivity) OR TI (Sedentary behavior OR Sitting activity OR Sedentary inactivity)) OR (AB (Well-being OR Wellness OR Wealth OR Welfare) OR TI (Well-being OR Wellness OR Wealth OR Welfare)) ) ) |
|
| ( (‘covid 19’:ab,ti OR ‘sars cov 2’:ab,ti OR coronavirus:ab,ti OR ‘corona virus’:ab,ti) AND (‘physical activity’:ab,ti OR sport:ab,ti OR sports:ab,ti OR exercise:ab,ti OR exercising:ab,ti OR ‘physical training’:ab,ti OR ‘physical performance’:ab,ti) OR (‘covid 19’:ab,ti OR ‘sars cov 2’:ab,ti OR coronavirus:ab,ti OR ‘corona virus’:ab,ti) AND (‘sedentary behavior’:ab,ti OR ‘sitting activity’:ab,ti OR ‘sedentary inactivity’:ab,ti) OR (‘covid 19’:ab,ti OR ‘sars cov 2’:ab,ti OR coronavirus:ab,ti) AND (‘well being’:ab,ti OR wellness:ab,ti OR wealth:ab,ti OR welfare:ab,ti) AND english:la AND [2019–2020]/py ) |
Inclusion and exclusion criteria.
| Inclusion Criteria | Exclusion Criteria | |
|---|---|---|
|
|
The study reports on the impact of the COVID-19 pandemic on physical activity, sedentary behavior, and/or well-being in adults (>18 years) with a physical disability and/or chronic diseases. | |
|
|
The study is about people with a physical disability and/or chronic disease. Physical disability is defined here as “an umbrella term for motor impairments, activity limitations and participation restrictions. It denotes the negative aspects of the interaction between an individual and that individual’s contextual factors” [ |
The study is about people without a disability and/or chronic disease. The study is about people with a visual, hearing, intellectual and/or psychological disability. The study is about children and/or youth. |
|
|
Not applicable | |
|
|
The study compares the situation before the COVID-19 pandemic with the situation in the COVID-19 pandemic. | |
|
|
The study reports on the impact of COVID-19 pandemic on | |
|
|
The study is a primary data study (e.g., cross-sectional, randomized controlled trials, observational etc.). |
The study is an integrative method (e.g., reviews, meta-analysis, editorials, commentary etc.). |
|
|
The study is published between 1 December 2019 and 30 September 2020. The study is published in English. |
The study is published after 30 September 2020. |
List of excluded articles during full-text screening.
| Reference | Exclusion Criteria |
|---|---|
| Balducci and Coccia (2020) [ | Study is a commentary (out of study design). |
| Bonora et al. (2020) [ | Study reported different outcomes (out of outcomes). |
| Boyle et al. (2020) [ | Study is a commentary (out of study design). |
| Chung et al. (2020) [ | Study has a too young population (out of population). |
| Cuschieri and Grech (2020) [ | Study is a literature study (out of study design). |
| Fernandez-del-Valle et al. (2020) [ | Study is a commentary (out of study design). |
| Giebel et al. (2020) [ | Study reported effects in dementia (out of population). |
| Hall and Church (2020) [ | Study is a review (out of study design). |
| Hudson and Sprow (2020) [ | Study is a commentary (out of study design). |
| Jakiela et al. (2020) [ | Study is a recommendation (out of study design). |
| Leung et al. (2020) [ | Study is a review (out of study design). |
| López-Sánchez et al. (2020) [ | Study is published on 10 October (out of publish date). |
| Mobasheri (2020) [ | Study is an editorial (out of study design). |
| Moghadasi (2020) [ | Study did not make a comparison with situation before the COVID-19 pandemic (out of comparison). |
| Motl et al. (2020) [ | Study is an editorial (out of study design). |
| Orhurhu et al. (2020) [ | Study is an editorial (out of study design). |
| Palmer et al. (2020) [ | Study is a review (out of study design). |
| Peçanha et al. (2020) [ | Study is a review (out of study design). |
| Quinn et al. (2020) [ | Study is an implementation study (out of study design). |
| Rhodes et al. (2020) [ | Study is a recommendation (out of study design). |
| Sennott et al. (2020) [ | Study is a commentary (out of study design). |
| Speretta and Leite (2020) [ | Study is an editorial (out of study design). |
| Tornese et al. (2020) [ | Study has a too young population (out of population). |
| Verma et al. (2020) [ | Study has a too young population (out of population). |
Figure 1Flowchart of literature search.
The study characteristics of the included studies.
| Author and Year | Country | Design | Type of Disability or Health Condition | Participants (n) | Age (Year) and Gender |
|---|---|---|---|---|---|
| Barone et al. (2020) [ | Brazil | CS | Diabetes Mellitus | 1701 | Age: 18–30: 395, 30–40: 453, 40–50: 351, 50–60: 271, 60–70: 164, 70–80: 59, 80>: 8 |
| Khader et al. (2020) [ | India | CS | Diabetes Mellitus | 1510 | Age: 41.6 |
| Yan et al. (2020) [ | China | CS | Diabetes Mellitus | 9016 (DM: 585, no DM: 8431) | Age: 18–80 |
| Assaloni et al. (2020) [ | Italy | OS | Type 1 Diabetes Mellitus | 154 | Age: 44.8 ± 12.5 |
| Khare et al. (2020) [ | India | OS | Type 2 Diabetes Mellitus | 143 | Age: 54.68 ± 9.22 |
| Munekawa et al. (2020) [ | Japan | CS | Type 2 Diabetes Mellitus | 203 | Age: 67.4 ± 11.3 |
| Ruiz-Roso et al. (2020) [ | Spain | CS | Type 2 Diabetes Mellitus | 72 | Age: 63 (44–77) |
| Sankar et al. (2020) [ | India | CS | Type 2 Diabetes Mellitus | 110 | Age: 58.7 ± 10.8 |
| Brown et al. (2020) [ | USA/World | CS | Parkinson’s disease (PD) | 7209 (PD: 5429, No PD: 1780) | Age: 19–95 |
| Schirinzi et al. (2020) [ | Italy | CS | Parkinson’s disease | 74 | Age: 61.3 ± 9.3 |
| Shalash et al. (2020) [ | Egypt | CS | Parkinson’s disease | 58 (PD: 38, No PD: 20) | Age: PD: 55.579 ± 9.956, No PD: 55.550 ± 5.708 |
| Song et al. (2020) [ | South Korea | CS | Parkinson’s disease | 100 | Age: 70 (62.3–76.0) |
| Van der Heide et al. (2020) [ | The Netherlands | CS | Parkinson’s disease | 358 | Age: 62.8 ± 9.0 |
| Chagué et al. (2020) [ | France | PC-RCT | Congestive heart failure | 124 | Age: 71.0 ± 4.0 |
| Vetrovsky et al. (2020) [ | Czech Republic | PC-RCT | Heart failure | 26 | Age: 58.8 ± 9.8 |
| Malanchini et al. (2020) [ | Italy | OS | Chronic cardiovascular disease | 184 | Age: 67 ± 14 |
| Sassone et al. (2020) [ | Italy | OS | Implantable cardioverter-defibrillators | 24 | Age: 72 ± 10 |
| Cransac-Miet et al. (2020) [ | France | CS | Chronic Coronary Syndromes | 195 | Age: 65.5 ± 11.1 |
| Elran-Barak et al. (2020) [ | Israel | CS | Chronic diseases | 315 | Age: 18–45: 60, 46–55: 43, 56–65: 69, 66–75: 107, 76>: 33 |
| Saqib et al. (2020) [ | Pakistan | CS | Chronic diseases | 181 | Age: 18–35: 75, 36–55: 52, 55>: 54 |
| Umucu et al. (2020) [ | USA | CS | Self-reported disabilities and chronic conditions | 269 | Age: 39.37 ± 12.18 |
| Havermans et al. (2020) [ | Belgium | CS | Cystic Fibrosis | 219 | Age: 16–67 |
| Radtke et al. (2020) [ | Switzerland | CS | Cystic Fibrosis | 327 | Age: 72.5% <40, 27.5% >40 |
| Chiaravalloti et al. (2020) [ | Italy/UK/Canada/Denmark/Belgium/USA | PC-RCT | Progressive Multiple Sclerosis | 131 | Age: 52,1 ± 9.6 |
| Endstrasser et al. (2020) [ | Austria | PC | Osteoarthritis | 63 | Age: 62.4 ± 11.84 |
| Di Stefano et al. (2020) [ | Italy | CS | Neuromuscular diseases | 268 (NM: 149, No NM: 119) | Age: 57.3 ± 13.7 (NM) 56 ± 6.8 (no NM) |
| Van de Venis et al. (2020) [ | The Netherlands | CS | Hereditary spastic paraplegia | 58 | Age: 57 (range 30–77) |
| Guo et al. (2020) [ | China | CS | Skin diseases | 506 | Age: 33.5 ± 14.0 |
| Al-Hashel et al. (2020) [ | Kuwait | CS | Migraine | 1018 | Age: <20: 38, 20–40: 733, 40–60: 235, 60>: 12 |
Note: cross-sectional study, CS; observational study, OS; prospective cohort study within an ongoing randomized clinical trial, PC-RCT; prospective cohort study, PC; male, M; female, F.
Key findings regarding physical activity during the first wave of the COVID-19 pandemic.
| Author and Year | Type of Disability or Health Condition | PA Construct | Method | Primary Results | Change in PA * |
|---|---|---|---|---|---|
| Barone et al. (2020) [ | Diabetes Mellitus | Change in PA | 5-Likert scale question | 59.5% reported a decrease in PA. | − |
| Khader et al. (2020) [ | Diabetes Mellitus | Change in PA | 3-Likert scale question | 69.07% reported a decrease in PA. | − |
| Yan et al. (2020) [ | Diabetes Mellitus | Changes in PA | International Physical Activity Questionnaire (IPAQ) | 67.7% with diabetes (vs. 41.2% without diabetes) reported an increased level of PA. | + |
| Assaloni et al. (2020) [ | Type 1 Diabetes Mellitus | Type of exercise | Godin-Leisure Time Exercise questionnaire (GLTEQ), Activity Tracker | Significant decrease in perceived and measured PA level. | − |
| khare et al. (2020) [ | Type 2 Diabetes Mellitus | Change in type | 2-Likert scale question | 80.42% reported a change in type. | − |
| Munekawa et al. (2020) [ | Type 2 Diabetes Mellitus | Change in exercise | Visual analogue scale (VAS) | 53.69% reported a decrease in exercise level. | − |
| Ruiz-Roso et al. (2020) [ | Type 2 Diabetes Mellitus | Change in PA | IPAQ | Significant increase in the daily hours that the participants of the study were sitting without doing any PA at all. | − |
| Sankar et al. (2020) [ | Type 2 Diabetes Mellitus | Change in PA | Face-to-face interview | 82.7% reported no major change in PA. | |
| Brown et al. (2020) [ | Parkinson’s disease | Change in exercise | 4-Likert scale question | 21% reported a cancelled/disrupted exercise. | −/* |
| Schirinzi et al. (2020) [ | Parkinson’s disease | Motor activity habits | International Physical Activity Questionnaire—Short Form (IPAQ-SF) | No change in total patients playing sports. | * |
| Shalash et al. (2020) [ | Parkinson’s disease | Change in PA | IPAQ-SF, Parkinson’s Disease questionnaire (PDQ39), 2-Likert scale COVID questions | Significant decline in physical activity. | − |
| Song et al. (2020) [ | Parkinson’s disease | Change in exercise (amount, duration and frequency) | Physical Activity Scale of the Elderly (PASE) questionnaire | Significant decrease in the amount of exercise. | − |
| Van der Heide et al. (2020) [ | Parkinson’s disease | Change in PA | 5-Likert scale question | 46.6% were physically less active. | − |
| Chagué et al. (2020) [ | Congestive heart failure | Change in PA | Telephone interview | 41.9% reported a decreased PA. | − |
| Vetrovsky et al. (2020) [ | Heart failure | Daily number of steps | Wrist-worn accelerometer | 16% decrease of daily step count. | − |
| Malanchini et al. (2020) [ | Chronic cardiovascular disease | Activity level (h/day) | Implanted devices | Decrease in PA of 0.5 h per day, a decrease of more than 25% compared with the activity during the pre-lockdown period and reference period. | − |
| Sassone et al. (2020) [ | Implantable cardioverter-defibrillators | Change in PA | Implantable cardioverter-defibrillator | Mean 25% reduction of PA was observed. | − |
| Cransac-Miet et al. (2020) [ | Chronic Coronary Syndromes | Change in PA | Telephone interview | 45% declared >25% reduction in PA. | − |
| Elran-Barak et al. (2020) [ | Chronic diseases | Level of PA | Adapted Medical Outcomes Study-Short Form 36 items (SF-36 MOS) | Significant decrease in PA. | − |
| Saqib et al. (2020) [ | Chronic diseases | Change in daily exercise | 2-Likert scale question | 66% could not continue their daily exercise. | − |
| Havermans et al. (2020) [ | Cystic Fibrosis | Change in exercise | 2-Likert scale (yes/no) | 53.2% of the adult CF patients reported they were not exercising more. | −/* |
| Radtke et al. (2020) [ | Cystic Fibrosis | Change in PA | VAS | 44.8% reported decreased PA. | − |
| Endstrasser et al. (2020) [ | Osteoarthritis | Change in daily activity | Tegner activity scale (TAS) | Significant decreased level of activity. | − |
| Di Stefano et al. (2020) [ | Neuromuscular diseases | Total PA level MVPA level (moderate-intensity and vigorous-intensity) | IPAQ-SF (adapted version) | Significant reduction of PA was reported for walking activity, total PA level and MVPA level, while no difference was found for vigorous-intensity PA and moderate-intensity PA. | − |
| Van de Venis et al. (2020) [ | Hereditary spastic paraplegia | Change in PA | 5-Likert scale question | 74% reported a reduction of PA. | − |
| Al-Hashel et al. (2020) [ | Migraine | Level of exercise | 2-Likert scale question | 79.7% reported an increased lack of regular exercise. | − |
Note: * Change in physical activity during the COVID-19 pandemic compared with before the pandemic. A positive change (+) indicates an increase in physical activity, no change (*) indicates no change in physical activity and a negative change (−) indicates a decrease in physical activity during the COVID-19 pandemic compared with before the start of the pandemic.
Different physical activity measurements used in the included studies.
| Self-Reported Measurements | Accelerometry | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Author and Year | LS | GLTEQ | IPAQ | IPAQ-SF | IV | PD Q39 | PASE | SF-36 MOS | TAS | VAS | AT | ID | AM | Change in PA * |
| Barone et al. (2020) [ | ✓ | − | ||||||||||||
| Khader et al. (2020) [ | ✓ | − | ||||||||||||
| Yan et al. (2020) [ | ✓ | + | ||||||||||||
| Assaloni et al. (2020) [ | ✓ | ✓ | − | |||||||||||
| Khare et al. (2020) [ | ✓ | − | ||||||||||||
| Munekawa et al. (2020) [ | ✓ | − | ||||||||||||
| Ruiz-Roso et al. (2020) [ | ✓ | − | ||||||||||||
| Sankar et al. (2020) [ | ✓ | * | ||||||||||||
| Brown et al. (2020) [ | ✓ | −/* | ||||||||||||
| Schirinzi et al. (2020) [ | ✓ | * | ||||||||||||
| Shalash et al. (2020) [ | ✓ | ✓ | ✓ | − | ||||||||||
| Song et al. (2020) [ | ✓ | − | ||||||||||||
| Van der Heide et al. (2020) [ | ✓ | − | ||||||||||||
| Chagué et al. (2020) [ | ✓ | − | ||||||||||||
| Vetrovs-ky et al. (2020) [ | ✓ | − | ||||||||||||
| Malanchini et al. (2020) [ | ✓ | − | ||||||||||||
| Sassone et al. (2020) [ | ✓ | − | ||||||||||||
| Cransac-Miet et al. (2020) [ | ✓ | − | ||||||||||||
| Elran-Barak et al. (2020) [ | ✓ | − | ||||||||||||
| Saqib et al. (2020) [ | ✓ | − | ||||||||||||
| Havermans et al. (2020) [ | ✓ | −/* | ||||||||||||
| Radtke et al. (2020) [ | ✓ | − | ||||||||||||
| Endstrasser et al. (2020) [ | ✓ | − | ||||||||||||
| Di Stefa-no et al. (2020) [ | ✓ | − | ||||||||||||
| Van de Venis et al. (2020) [ | ✓ | − | ||||||||||||
| Al-Hashel et al. (2020) [ | ✓ | − | ||||||||||||
Note: * Change in physical activity during the COVID-19 pandemic compared with before the pandemic. A positive change (+) indicates an increase in physical activity, no change (*) indicates no change in physical activity and a negative change (−) indicates a decrease in physical activity during the COVID-19 pandemic compared with before the start of the pandemic. Likert scale, LS; Godin-Leisure Time Exercise questionnaire, GLTEQ; International Physical Activity Questionnaire, IPAQ; International Physical Activity Questionnaire—Short Form, IPAQ-SF; Interview, IV; Parkinson’s Disease questionnaire, PDQ39; Physical Activity Scale of the Elderly, PASE; Medical Outcomes Study-Short Form 36 items, SF-36 MOS; Tegner activity scale, TAS; Visual analogue scale, VAS; activity tracker, AT; implanted devices, ID; accelerometer, AM.
Key findings regarding well-being during the first wave of the COVID-19 pandemic.
| Author and Year | Type of Disability or Health Condition | WB Constructs | Method | Primary Results | Change in Well-Being * |
|---|---|---|---|---|---|
| Sankar et al. (2020) [ | Type 2 Diabetes Mellitus | Stress | Hospital Anxiety and Depression Scale (HADS) | 15.5% increased mental stress and higher anxiety levels. | − |
| Schirinzi et al. (2020) [ | Parkinson’s disease | Depression | Parkinson’s Well-Being Map (PWBM), Beck Depression Index (BDI) | 59.5% perception of worsening in global health during COVID. | − |
| Shalash et al. (2020) [ | Parkinson’s disease | Mental health | Depression, Anxiety, and Stress scale-21 (DASS-21), PD questionnaire (PDQ39), 2-Likert scale COVID questions | Compared with control group: significant worse stress, depression, anxiety and total DASS. | − |
| Van der Heide et al. (2020) [ | Parkinson’s disease | Perceived stress | DynaCORE-C, Perceived Stress Scale (PSS), Unified Parkinson’s Disease Rating Scale part Ib and II (MDS-UPDRS-self), Parkinson Anxiety Scale (PAS), Ruminative Response Scale (RRS), List of external stressors | Higher levels of stress and anxiety. | − |
| Chagué et al. (2020) [ | Congestive heart failure | Self-reported well-being | Psychological distress --> Kessler 6 score (K6) | 21.8% reported a decrease in well-being. | − |
| Elran-Barak et al. (2020) [ | Chronic diseases | (Change in) physical self-reported health (SRH) | Adapted Medical Outcomes Study-Short Form 36 items (SF-36 MOS) | 47.2% reported decline in physical SRH. | − |
| Saqib et al. (2020) [ | Chronic diseases | Self-reported overall health | 2-Likert scale question | 44.75% reported an effect on self-reported overall health. | − |
| Umucu et al. (2020) [ | Self-reported disabilities and chronic conditions | Perceived stress | Perceived stress questionnaire-8, Brief COPE, PERMA-Profiler, Patient Health Questionnaire-4 | Small negative impact on well-being: moderate level of stress, depression and anxiety during the COVID pandemic. | − |
| Havermans et al. (2020) [ | Cystic Fibrosis | Emotional well-being Changes in behavior or worries about CF | 2-point Likert scale | Patients reported more sadness, discouragement, feelings of helplessness, perception of deterioration and difficulty with adhering to their routine. | − |
| Chiaravalloti et al. (2020) [ | Progressive Multiple Sclerosis | Change in level of depression, anxiety, overall quality of life | COVID Impact survey | Increased anxiety and depression. | − |
| Endstrasser et al. (2020) [ | Osteoarthritis | Change in pain and mental health | Visual analogue scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Short-Form Health Survey (SF-12) | VAS and WOMAC scores increased significantly during lockdown. | − |
| Van de Venis et al. (2020) [ | Hereditary spastic paraplegia | Change in psychological stress | 5-Likert scale question | 43% reported an increase in psychological stress. | − |
| Guo et al. (2020) [ | Skin diseases | Perceived stress | VAS, Perceived Stress Scale 14 item (PSS-14) | Increased symptoms of anxiety and depression. | − |
Note: * Change in one or more constructs related to well-being. A negative change (−) indicates a decrease or decline in one or more well-being constructs during the COVID-19 pandemic compared with before the start of the pandemic. Well-being = WB.
Different well-being constructs used in the included studies.
| Author and Year | Anxiety | Depression | Loneliness | Mental Health | Overall Health | Pain | Quality of Life | Stress | Well-Being | Change in Well-Being |
|---|---|---|---|---|---|---|---|---|---|---|
| Sankar et al. (2020) [ | ✓ | ✓ | − | |||||||
| Schirinzi et al. (2020) [ | ✓ | − | ||||||||
| Shalash et al. (2020) [ | ✓ | − | ||||||||
| Van der Heide et al. (2020) [ | ✓ | − | ||||||||
| Chagué et al. (2020) [ | ✓ | ✓ | − | |||||||
| Elran-Barak et al. (2020) [ | ✓ | ✓ | − | |||||||
| Saqib et al. (2020) [ | ✓ | − | ||||||||
| Umucu et al. (2020) [ | ✓ | ✓ | ✓ | ✓ | − | |||||
| Havermans et al. (2020) [ | ✓ | ✓ | ✓ | − | ||||||
| Chiaravalloti et al. (2020) [ | ✓ | ✓ | − | |||||||
| Endstrasser et al. (2020) [ | ✓ | ✓ | − | |||||||
| Van de Venis et al. (2020) [ | ✓ | − | ||||||||
| Guo et al. (2020) [ | ✓ | ✓ | ✓ | ✓ | − |
Note: Change in one or more constructs related to well-being. A negative change (−) indicates a decrease or decline in one or more well-being constructs during the COVID-19 pandemic compared with before the start of the pandemic.